NCT06964555View on ClinicalTrials.gov

Effect of Intravenous Low-Dose Ketamine Infusion With Intravenous Lignocaine Infusion on Post-Operative Pain in Patients Undergoing Laparoscopic Choleysystectomy Under General Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Cholelithiases
Interventions
DRUG

Intravenous Ketamine Infusions

Ketamine group received ketamine at 0.2mg/kg bolus intravenously followed by ketamine infusion at rate of 0.2mg/kg/hr throughout the surgery.

DRUG

Intravenous lignocaine

IV Lignocaine was given at the rate of 1 mg/kg/hr.

Trial Locations (1)

75510

Fazaia Ruth Pfau Medical College, Karachi

All Listed Sponsors
lead

Fazaia Ruth Pfau Medical College

OTHER

NCT06964555 - Effect of Intravenous Low-Dose Ketamine Infusion With Intravenous Lignocaine Infusion on Post-Operative Pain in Patients Undergoing Laparoscopic Choleysystectomy Under General Anesthesia | Biotech Hunter | Biotech Hunter